Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2012
03/01/2012US20120052042 Amphiphilic compounds and self-assembling compositions made therefrom
03/01/2012US20120052040 Polymer compositions and methods for their use
03/01/2012US20120052022 Composition for oral health treatment and related methods of use
03/01/2012US20120052012 Highly biocompatible dual thermogelling chitosan/glucosamine salt compositions
03/01/2012DE202012100195U1 Neue Verwendung einer pharmazeutischen Zusammensetzung, enthaltend Ancrod New use of a pharmaceutical composition comprising ancrod
03/01/2012DE102010036261A1 New peptide having a length of two to five monomers, where the monomers are an alpha hydroxy-4(1H)-pyridinone compounds, useful to treat metal (preferably iron, copper or aluminum) storage disorders, preferably siderosis
03/01/2012CA2809415A1 Cell-protective peptides and uses thereof
03/01/2012CA2809362A1 Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
03/01/2012CA2809153A1 Immunotherapeutic method for treating prostate cancer
03/01/2012CA2809093A1 Compositions and uses of materials with high antimicrobial activity and low toxicity
03/01/2012CA2808978A1 Compositions for gastric delivery of active agents
03/01/2012CA2808539A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases
03/01/2012CA2808282A1 Improved enteric active substance delivery
03/01/2012CA2808225A1 Compositions and methods for cardiac therapy
03/01/2012CA2808126A1 Nutritional products having improved organoleptic properties
02/2012
02/29/2012EP2423311A1 Method for preparing cell pharmaceutical
02/29/2012EP2423310A1 Cancer antigen helper peptide
02/29/2012EP2423307A1 Modified coagulation factor IV polypeptides and use thereof for treatment
02/29/2012EP2423306A1 Modified coagulation factor IX polypeptides and use thereof for treatment
02/29/2012EP2423305A1 Modified coagulation factor IX polypeptides and use thereof for treatment
02/29/2012EP2423224A1 Compositions and methods for modulating hemostasis
02/29/2012EP2423223A1 Novel exendin variant and conjugate thereof
02/29/2012EP2423222A1 Regulatory t cell epitopes, compositions and uses thereof
02/29/2012EP2423221A1 Regulatory t cell epitopes, compositions and uses thereof
02/29/2012EP2423220A1 Regulatory T cell epitopes, compositions and uses thereof
02/29/2012EP2423219A1 Regulatory t cell epitopes, compositions and uses thereof
02/29/2012EP2422814A1 Remedy for cartilage-related diseases
02/29/2012EP2422812A1 Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury
02/29/2012EP2422808A2 Novel compounds and their effects on feeding behaviour
02/29/2012EP2422807A2 Hybrid polypeptides with selectable properties
02/29/2012EP2422806A2 Hybrid polypeptides with selectable properties
02/29/2012EP2422804A1 Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers
02/29/2012EP2422770A1 Formulations of peg-interferon alpha conjugates
02/29/2012EP2422765A1 Ophthalmic compositions and methods for treating eyes
02/29/2012EP2421953A1 Method for chondrogenic differentiation of pluripotent or multipotent stem cells using wnt6
02/29/2012EP2421901A2 Compositions containing hc ha complex and methods of use thereof
02/29/2012EP2421894A1 Method of preparing low-iron lactoferrin
02/29/2012EP2421554A1 Tissue kallikrein for the treatment of huntington's disease
02/29/2012EP2421553A1 Tissue kallikrein for the treatment of schizophrenia and bipolar disorder
02/29/2012EP2421552A1 Compositions for use in the treatment of chronic obstructive pulmonary diseases and asthma
02/29/2012EP2421551A2 Silk fibroin hydrogels and uses thereof
02/29/2012EP2421550A2 Silk fibroin hydrogels and uses thereof
02/29/2012EP2421549A2 Silk fibroin hydrogels and uses thereof
02/29/2012EP2421548A1 Use of (hexenoyl trans-3)hgrf(l-44)nh2 and simvastatin in combination therapy
02/29/2012EP2421547A1 Use of (hexenoyl trans-3)hgrf(1-44)nh2 and ritonavir in combination therapy
02/29/2012EP2421546A1 Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
02/29/2012EP2421545A1 Method and composition for synchronizing time of insemination
02/29/2012EP2421529A2 Siderophore conjugate immunogenic compositions and vaccines
02/29/2012EP2421524A2 Chemosensory receptor ligand-based therapies
02/29/2012EP2421520A1 Pharmaceutical compositions for the treatment of nasal polyposis
02/29/2012EP2421511A1 Method for the production of commercial nanoparticle and microparticle powders
02/29/2012EP2407175A9 Agents with angiogenic and wound healing activity
02/29/2012EP2224941B1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
02/29/2012EP2178903B1 Optimized dengue virus entry inhibitory peptide (dn81)
02/29/2012EP2099913B1 Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions
02/29/2012EP2037949B1 A method of manufacturing a transfer factor medicament
02/29/2012EP1827461B1 Cladribine regimen for treating multiple sclerosis
02/29/2012EP1740213B1 Liquid growth hormone formulation
02/29/2012EP1641487B1 Liquid composition of factor vii polypeptides
02/29/2012EP1638567B1 Composition comprising a pulmonary surfactant and sildenafil for the treatment of lung diseases
02/29/2012EP1636208B1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
02/29/2012EP1626987B1 Deer antler extract for promoting angiogenesis
02/29/2012EP1576112B1 Cytokine receptor zcytor17 multimers
02/29/2012EP1572725B1 Chi-conotoxin peptides having a n-terminal pyroglutamic acid
02/29/2012EP1390383B1 Antisense permeation enhancers
02/29/2012EP1325133B1 Bvh-a2 and bvh-a3 antigens of group b streptococcus
02/29/2012CN1908010B Furin enzyme inhibitor of resisting HIV-1 and preparation method thereof
02/29/2012CN1792222B Process for the preparation of a powder containing glucopyranosyl-alditols cristalline particules
02/29/2012CN102365295A Conformationally dynamic peptides
02/29/2012CN102365294A Dipeptide mimetics of ngf and bdnf neurotrophins
02/29/2012CN102365112A Compositions for the treatment of gluten intolerance and uses thereof
02/29/2012CN102365094A Cyclosporin analogues for preventing or treating hepatitis c infection
02/29/2012CN102365093A Prophylactic or therapeutic agent for retinal diseases and method for preventing or treating retinal diseases, each comprising jnk (c-jun n-terminal kinase)-inhibiting peptide, and use of the peptide
02/29/2012CN102363784A Ruditapes philippinarum Defensin B gene, its recombinant protein and application
02/29/2012CN102363783A Venerupis philippinarum defensin A gene, and recombinant protein and application thereof
02/29/2012CN102363633A Glucagon like peptide-1 mutant polypeptide and preparation method, medicinal composition and use thereof
02/29/2012CN102363629A Protein for treating eye angiogenesis
02/29/2012CN102363628A Protein with cardiac muscle cell apoptosis resisting function, preparation method and application thereof
02/29/2012CN102363627A Oligopeptide A and antibacterial use thereof
02/29/2012CN102363040A Antimicrobial peptide preparation for mucosal tissues
02/29/2012CN102362874A Leech colon targeted oral preparation and preparation method thereof
02/29/2012CN102362856A Recombinant bovine basic fibroblast grow factor external solution
02/29/2012CN102120032B Water-soluble substrate suitable for preparing water-soluble preparations of bleomycin and homologues thereof
02/29/2012CN101926999B Hemostatic disinfectant and preparation method thereof
02/29/2012CN101921313B Polypeptide for curing or preventing cancer or derivative product and application thereof
02/29/2012CN101892252B Gene for encoding muramidase and application of same
02/29/2012CN101798336B Anti-tumour compound with tracking function
02/29/2012CN101537176B Application of staphylococcus lysozyme compound in preparing medicament improving animal health condition
02/29/2012CN101484579B High-affinity antagonists of elr-cxc chemokines
02/29/2012CN101287483B Pharmaceutical compositions and methods for accelerating wound healing
02/29/2012CN101273995B Method for preparing magnetic particles modified by afi-tiazin dyes
02/29/2012CN101267830B Growth hormone secretagogues
02/29/2012CN101189022B Adrenocorticotropic hormone analogs and related methods
02/29/2012CN101171032B Use of native peptides and their optimized derivatives for vaccination
02/28/2012US8124747 Novel hepatitis C viral sequences for use as tool in detection, treatment and prevention of viral infection; immunotherapy; immunodiagnostics
02/28/2012US8124741 Antibodies to tumor associated proteins
02/28/2012US8124737 Stabilized preparations of serine endopeptidases, their preparation and use
02/28/2012US8124735 Porous keratin construct and method of making the same
02/28/2012US8124733 Tumor suppressor gene
02/28/2012US8124732 Composition comprising isolated human CTLA4-Fc fusion protein produced in a transgenic chicken
1 ... 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 ... 3163